Literature DB >> 15034223

Ion channels and amino acid transporters support the growth and invasion of primary brain tumors.

Harald Sontheimer1.   

Abstract

The malignant growth of glial support cells causes gliomas, highly invasive, primary brain tumors that are largely resistant to therapy. Individual tumor cells spread by active cell migration, invading diffusely into the normal brain. This process is facilitated by Cl- channels that endow glioma cells with an enhanced ability to quickly adjust their shape and cell volume to fit the narrow and tortuous extracellular brain spaces. Once satellite tumors enlarge, their growth is limited by the spatial constraints imposed by the bony cavity of the skull and spinal column. Glioma cells circumvent this limitation by active destruction of peritumoral neural tissue through the release of glutamate, inducing peritumoral seizures and ultimately excitotoxic neuronal cell death. Hence, primary brain tumors support their unusual biology by taking advantage of ion channels and transporters that are designed to support ion homeostatic functions in normal brain.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15034223      PMCID: PMC2548410          DOI: 10.1385/MN:29:1:61

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  46 in total

Review 1.  Malignant glioma: genetics and biology of a grave matter.

Authors:  E A Maher; F B Furnari; R M Bachoo; D H Rowitch; D N Louis; W K Cavenee; R A DePinho
Journal:  Genes Dev       Date:  2001-06-01       Impact factor: 11.361

2.  Glutamate release in severe brain ischaemia is mainly by reversed uptake.

Authors:  D J Rossi; T Oshima; D Attwell
Journal:  Nature       Date:  2000-01-20       Impact factor: 49.962

3.  Role of lysophosphatidic acid and rho in glioma cell motility.

Authors:  T J Manning; J C Parker; H Sontheimer
Journal:  Cell Motil Cytoskeleton       Date:  2000-03

Review 4.  Molecular structure and physiological function of chloride channels.

Authors:  Thomas J Jentsch; Valentin Stein; Frank Weinreich; Anselm A Zdebik
Journal:  Physiol Rev       Date:  2002-04       Impact factor: 37.312

5.  Dibutyryl-cAMP (dbcAMP) up-regulates astrocytic chloride-dependent L-[3H]glutamate transport and expression of both system xc(-) subunits.

Authors:  G E Gochenauer; M B Robinson
Journal:  J Neurochem       Date:  2001-07       Impact factor: 5.372

6.  Inhibition of matrix metalloproteinase MMP-2 activates chloride current in human airway epithelial cells.

Authors:  M Duszyk; Y Shu; G Sawicki; A Radomski; S F Man; M W Radomski
Journal:  Can J Physiol Pharmacol       Date:  1999-07       Impact factor: 2.273

Review 7.  Glutamate uptake.

Authors:  N C Danbolt
Journal:  Prog Neurobiol       Date:  2001-09       Impact factor: 11.685

8.  Volume-activated chloride currents contribute to the resting conductance and invasive migration of human glioma cells.

Authors:  C B Ransom; J T O'Neal; H Sontheimer
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

9.  Glutamate release promotes growth of malignant gliomas.

Authors:  T Takano; J H Lin; G Arcuino; Q Gao; J Yang; M Nedergaard
Journal:  Nat Med       Date:  2001-09       Impact factor: 53.440

10.  Chlorotoxin-sensitive Ca2+-activated Cl- channel in type R2 reactive astrocytes from adult rat brain.

Authors:  Stanislava Dalton; Volodymyr Gerzanich; Mingkui Chen; Yafeng Dong; Yaroslav Shuba; J Marc Simard
Journal:  Glia       Date:  2003-06       Impact factor: 7.452

View more
  37 in total

1.  With-No-Lysine Kinase 3 (WNK3) stimulates glioma invasion by regulating cell volume.

Authors:  Brian R Haas; Vishnu A Cuddapah; Stacey Watkins; Katie Jo Rohn; Tiffany E Dy; Harald Sontheimer
Journal:  Am J Physiol Cell Physiol       Date:  2011-08-03       Impact factor: 4.249

2.  Expression and function of calcium-activated potassium channels in human glioma cells.

Authors:  Amy K Weaver; Valerie C Bomben; Harald Sontheimer
Journal:  Glia       Date:  2006-08-15       Impact factor: 7.452

3.  Inhibition of the Sodium-Potassium-Chloride Cotransporter Isoform-1 reduces glioma invasion.

Authors:  Brian R Haas; Harald Sontheimer
Journal:  Cancer Res       Date:  2010-06-22       Impact factor: 12.701

4.  Blood glutamate scavengers prolong the survival of rats and mice with brain-implanted gliomas.

Authors:  Angela Ruban; Tamara Berkutzki; Itzik Cooper; Boaz Mohar; Vivian I Teichberg
Journal:  Invest New Drugs       Date:  2012-02-02       Impact factor: 3.850

5.  A proinvasive role for the Ca(2+) -activated K(+) channel KCa3.1 in malignant glioma.

Authors:  Kathryn L Turner; Avinash Honasoge; Stephanie M Robert; Michael M McFerrin; Harald Sontheimer
Journal:  Glia       Date:  2014-03-02       Impact factor: 7.452

Review 6.  Molecular physiology of SPAK and OSR1: two Ste20-related protein kinases regulating ion transport.

Authors:  Kenneth B Gagnon; Eric Delpire
Journal:  Physiol Rev       Date:  2012-10       Impact factor: 37.312

7.  Water permeability through aquaporin-4 is regulated by protein kinase C and becomes rate-limiting for glioma invasion.

Authors:  E S McCoy; B R Haas; H Sontheimer
Journal:  Neuroscience       Date:  2009-09-15       Impact factor: 3.590

8.  Talampanel with standard radiation and temozolomide in patients with newly diagnosed glioblastoma: a multicenter phase II trial.

Authors:  Stuart A Grossman; Xiaobu Ye; Marc Chamberlain; Tom Mikkelsen; Tracy Batchelor; Serena Desideri; Steven Piantadosi; Joy Fisher; Howard A Fine
Journal:  J Clin Oncol       Date:  2009-07-27       Impact factor: 44.544

9.  Role of KCNMA1 gene in breast cancer invasion and metastasis to brain.

Authors:  Divya Khaitan; Umesh T Sankpal; Babette Weksler; Edward A Meister; Ignacio A Romero; Pierre-Olivier Couraud; Nagendra S Ningaraj
Journal:  BMC Cancer       Date:  2009-07-29       Impact factor: 4.430

10.  Glioblastoma cells express functional cell membrane receptors activated by daily used medical drugs.

Authors:  Susanne A Kuhn; Ulrike Mueller; Uwe-K Hanisch; Christian R A Regenbrecht; Ilona Schoenwald; Michael Brodhun; Hartwig Kosmehl; Christian Ewald; Rolf Kalff; Rupert Reichart
Journal:  J Cancer Res Clin Oncol       Date:  2009-06-19       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.